BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, April 19, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Financings for April 17, 2023

April 17, 2023
Med-tech firms raising money in public or private financings, including: Glucotrack.
Read More

Appointments and advancements for April 17, 2023

April 17, 2023
New hires and promotions in the med-tech industry, including: Endogastric Solutions, Icad, ITM Isotope Technologies, LivaNova, Precision Optics.
Read More

Biggest gainers and losers for April 10-14, 2023

April 17, 2023
The top 10 biopharma stock gainers and losers for the week.
Read More

Regulatory actions for April 17, 2023

April 17, 2023
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alvotech, Eli Lilly, Horizon, Ips, Minghui, Nicox, NS, Ocumension, Pfizer, Soligenix.
Read More

Other news to note for April 17, 2023

April 17, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Affini-T, Akthelia, Argenx, Athenex, Biomed, Caris, Eisai, Enzolytics, Flare, Genmab, Geovax, Gilead, Graf, Navidea, Meilleur, Nkgen, Smart Immune.
Read More

In the clinic for April 17, 2023

April 17, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astellas, Gilead, Mindmedicine, Minghui, Ocugen, Sunstone, Travere, Zenshine.
Read More

Financings for April 17, 2023

April 17, 2023
Biopharmas raising money in public or private financings, including: Inflarx.
Read More

Appointments and advancements for April 17, 2023

April 17, 2023
New hires and promotions in the biopharma industry, including: Amarin, Biohaven, Cormedix, Enlivex, Foresee, HLS, KBI, Rapid Dose, Regeneron.
Read More

Regulatory actions for April 14, 2023

April 14, 2023
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott, Clearpoint Neuro.
Read More

Other news to note for April 14, 2023

April 14, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aerwave, Autonomous Medical, Avita, Caregility, Keygene, Lucius Partners, Pillar Biosciences, Xandar Kardian.
Read More
Previous 1 2 … 798 799 800 801 802 803 804 805 806 … 1782 1783 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 17, 2026.
  • Man holding raised arm with illustrated overlay of nerves

    Biohaven reports details on discovery of BHV-2100

    BioWorld Science
    Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
  • Elderly woman holding illustration of brain with missing puzzle piece

    Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

    BioWorld
    The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 14, 2026
  • Novel caspase-2 inhibitor shows in vivo neuroprotective effects

    BioWorld Science
    Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing